Welcome to IPD-IMGT/HLA

Release 3.28.0, 2017-04-13

The IPD-IMGT/HLA Database provides a specialist database for sequences of the human major histocompatibility complex (MHC) and includes the official sequences named by the WHO Nomenclature Committee For Factors of the HLA System. The IPD-IMGT/HLA Database is part of the international ImMunoGeneTics project (IMGT).

The database uses the 2010 naming convention for HLA alleles in all tools herein. To aid in the adoption of the new nomenclature, all search tools can be used with both the current and pre-2010 allele designations. The pre-2010 nomenclature designations are only used where older reports or outputs have been made available for download.

Latest Publications

  • Robinson J, Halliwell JA, Hayhurst JH, Flicek P, Parham P, Marsh SGE
    The IPD and IPD-IMGT/HLA Database: allele variant databases
    Nucleic Acids Research (2015) 43:D423-431
  • For further IPD publications, please see our citations page.

Funding and Support

Disclaimer

Where discrepancies have arisen between reported sequences and those stored in the databases, the original authors have been contacted where possible, and necessary amendments to published sequences have been incorporated. Future sequencing may identify errors and the Nomenclature Committees would welcome any evidence that helps to maintain the accuracy of the database. We therefore make no warranties regarding the correctness of the data, and disclaim liability for damages resulting from its use. We cannot provide unrestricted permission regarding the use of the data, as some data may be covered by patents or other rights. Any medical or genetic information is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care.

Further Information

For more information about the database, queries (including website) or to subscribe to the IPD mailing lists please contact IPD Support.

Please see our licence for our terms of use.